The recently discovered chromosome 10q23-localised PTEN/MMAC1 gene ful®ls the criteria of a tumour suppressor gene. Loss of heterozygosity (LOH) is described for numerous human malignancies, and germ line mutations of PTEN are found in Cowden and Bannayan ± Riley ± Ruvalcaba syndrome families. Expression of PTEN cDNA in PTEN negative human glioblastoma cell lines leads to reduced proliferation and growth arrest. Only a few studies have been described linking PTEN mutations to sporadic prostate cancer which is known to be the most common male cancer in the Western world.
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Method
Forty tissue samples of primary prostate cancer were analysed after microdissection for LOH within the 10q23 region using 5 different primers (D10S583, AFMa086wg9, D10S1678, D10S532 and D10S2491). Mutation analysis was performed on the 14 tumours with LOH in the PTEN region by sequencing the PCR products.
Results
We found 14/40 (35%) primary prostate tumours to have LOH in the 10q23 region by microsatellite analysis with at least one of ®ve different markers. Sequence analysis of PTEN exons 1 ± 9 in PCs displaying LOH revealed 5 mutations in coding regions of the PTEN gene, and three intronic mutations.
Conclusion
The results are comparable to data published in the literature. A percentage of 35% LOH in the 10q23 region does not support a putative role of this particular tumour suppressor gene in the initiation of prostate cancer.
